Cerenome is trading 5.3% up now at $2.23 after no clear company-specific catalyst was identified for September 16, 2026.

  • The latest notable disclosure was a financing facility announced September 10, providing up to $20 million; it predates the move and does not directly explain the pre-market gain.
  • Broader markets are modestly higher ahead of September 16 Federal Reserve events, though the move remains below the stated 0.5% confirmation threshold.